Dr. Lydia Michaut holds a master’s degree in molecular and cellular biology and a Ph.D. in immunology from the University of Strasbourg and has 15 years of experience in fundamental research directly contributing important work in Balzan Prize- and Nobel Prize-winning academic laboratories. She then spent 10 years at Novartis, where she acquired a deep expertise of clinical regulated bioanalytics supporting PK, PD, and immunogenicity assessments of large molecule therapeutics, including gene therapies, before joining BioAgilytix in early 2019.